AG
BMY icon

AIA Group’s Bristol-Myers Squibb BMY Stock Holding History

AIA Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.62M Sell
149,569
-40,345
-21% -$2.32M 0.11% 109
2026
Q1 		$11.5M Buy
189,914
+31,842
+20% +$1.86M 0.17% 89
2025
Q4 		$8.53M Buy
158,072
+34,901
+28% +$1.68M 0.13% 111
2025
Q3 		$5.56M Sell
123,171
-4,819
-4% -$225K 0.1% 132
2025
Q2 		$5.92M Buy
127,990
+33,388
+35% +$1.64M 0.13% 92
2025
Q1 		$5.77M Buy
94,602
+70,858
+298% +$4.13M 0.14% 80
2024
Q4 		$1.34M Buy
23,744
+925
+4% +$51.7K 0.03% 185
2024
Q3 		$1.18M Sell
22,819
-19,862
-47% -$932K 0.03% 206
2024
Q2 		$1.77M Sell
42,681
-45,087
-51% -$2.02M 0.05% 159
2024
Q1 		$4.76M Buy
87,768
+31,792
+57% +$1.62M 0.16% 68
2023
Q4 		$2.87M Buy
55,976
+7,290
+15% +$383K 0.12% 86
2023
Q3 		$2.83M Buy
48,686
+8,764
+22% +$537K 0.14% 82
2023
Q2 		$2.55M Buy
39,922
+9,490
+31% +$636K 0.12% 81
2023
Q1 		$2.11M Sell
30,432
-802
-3% -$56.6K 0.11% 82
2022
Q4 		$2.25M Sell
31,234
-35,388
-53% -$2.67M 0.14% 65
2022
Q3 		$4.74M Buy
66,622
+25,468
+62% +$1.85M 0.31% 36
2022
Q2 		$3.17M Buy
41,154
+6,753
+20% +$514K 0.17% 56
2022
Q1 		$2.51M Buy
34,401
+21,122
+159% +$1.42M 0.11% 86
2021
Q4 		$828K Sell
13,279
-73,689
-85% -$4.32M 0.04% 148
2021
Q3 		$5.15M Buy
86,968
+61,982
+248% +$4.08M 0.29% 57
2021
Q2 		$1.66M Buy
24,986
+12,727
+104% +$830K 0.11% 88
2021
Q1 		$774K Buy
+12,259
New +$763K 0.11% 95

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AIA Group's BMY Position: Q2 2026 in Review

AIA Group reduced its Bristol-Myers Squibb (BMY) stake by 21% in Q2 2026, selling an estimated $2.32M and leaving 149,569 shares worth $8.62M. The position accounts for 0.11% of the portfolio, ranked #109.

AIA Group first reported a position in BMY in Q1 2021 and has held it in 22 quarters since. The position peaked at $11.5M in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • AIA Group held 149,569 shares of Bristol-Myers Squibb worth $8.62M as of Q2 2026.
  • AIA Group sold 40,345 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.32M.
  • Bristol-Myers Squibb made up 0.11% of AIA Group's portfolio in Q2 2026, its #109 holding.
  • AIA Group first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 22 quarters since.
  • AIA Group's Bristol-Myers Squibb position peaked at $11.5M in Q1 2026.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on AIA Group's 13F filing for Q2 2026, filed 31 Jul 2026.